Aristotle Capital Boston Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HealthEquity
HQY
|
+$25.7M |
| 2 |
Haemonetics
HAE
|
+$21.4M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$20.9M |
| 4 |
KBR
KBR
|
+$16.1M |
| 5 |
Huron Consulting
HURN
|
+$13.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
1-800-Flowers.com
FLWS
|
+$25.4M |
| 2 |
Silgan Holdings
SLGN
|
+$13.6M |
| 3 |
AEL
American Equity Investment Life Holding Company
AEL
|
+$6.81M |
| 4 |
Mercury Systems
MRCY
|
+$6.69M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$5.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.68% |
| 2 | Healthcare | 17.35% |
| 3 | Technology | 15.95% |
| 4 | Financials | 12.7% |
| 5 | Consumer Discretionary | 6.92% |
Similar funds
Aristotle Capital Boston's Q3 2020 Portfolio in Review
As of Q3 2020, Aristotle Capital Boston held 138 positions worth $3.45B, up 4.8% from $3.29B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aristotle Capital Boston deployed $157M of net new capital in Q3 2020, opening 6 new positions and adding to 106 existing holdings. Its largest new stake was HealthEquity: 468,666 shares worth $24.1M.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was 1-800-Flowers.com, an estimated $25.4M trimmed.
- Aristotle Capital Boston's largest Q3 2020 buy was HealthEquity: 468,666 shares worth $24.1M.
- Aristotle Capital Boston added most to Huron Consulting in Q3 2020, an estimated $13.4M increase.
- Aristotle Capital Boston's biggest Q3 2020 reduction was 1-800-Flowers.com, cutting an estimated $25.4M.
- Aristotle Capital Boston fully exited Noble Energy, Inc. in Q3 2020, selling an estimated $4.15M.
- Aristotle Capital Boston's ten largest holdings make up 20% of its $3.45B portfolio in Q3 2020.
- Aristotle Capital Boston opened 6 new positions and closed 1 in Q3 2020.
- Aristotle Capital Boston's portfolio value rose 4.8% quarter-over-quarter to $3.45B.
Based on Aristotle Capital Boston's 13F filing for Q3 2020, filed 16 Nov 2020.